HPR63 Plasma Last Liter Economics and Its Impact on the Costs of Major Human Polyvalent Immunoglobulins in Europe

Human polyvalent immunoglobulins (Igs) are plasma derivatives that treat primary immunodeficiencies for which there are no alternatives. Unlike small molecule pharmaceutical products, the cost of plasma derivatives increases with the volume manufactured. Increasing demand for Igs results in high collection and fractionation costs and reduces the viability for manufacturers to increase production volumes. This research aims to explore the cost evolution of plasma in Europe and to demonstrate how the increasing Ig demand has driven costs.

Source: Value in Health - December 1, 2023 Category: International Medicine & Public Health Authors: J. Galduf, M. Toumi, S. Neudoerfer, J. Sears, L. Marlow, J. Torres Ames Source Type: research